EyePoint Pharmaceuticals Inc (EYPT)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
LABORATORY ANALYTICAL INSTRUMENTS
CEO:
Nancy Sue Lurker
Employees:
44
480 PLEASANT STREET, SUITE B300, WATERTOWN, MA 02472
617-926-5000

EyePoint Pharmaceuticals Inc develops tiny, sustained-release products, which are designed to deliver drugs and biologics at a controlled and steady rate for weeks, months or years. The company through its technology platforms Duraser and Tethadur is focused on treatment of chronic diseases of the back of the eye and are also exploring applications outside ophthalmology. It is also developing a bioerodible, injectable micro-insert delivering latanoprost to treat glaucoma and ocular hypertension. pSivida was founded by Roger Aston in March 2008 and is headquartered in Waterson, MA.

Data derived from most recent annual or quarterly report
Market Cap 345.528 Million Shares Outstanding28.77 Million Avg 30-day Volume 107.089 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 15.06 / 3.51 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from EYPT instead.

View recent insider trading info

Funds Holding EYPT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EYPT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ANDO GORAN

14,750 2021-06-22 2

DICICCO WENDY F

13,500 2021-06-22 2

GUYER DAVID R

13,500 2021-06-22 2

GODSHALL DOUGLAS EVAN

19,016 2021-06-22 2

ELSTON GEORGE CHIEF FINANCIAL OFFICER

75,200 2021-06-22 1

LURKER NANCY PRESIDENT & CEO

266,300 2021-06-22 5

LANDIS JOHN B.

13,500 2021-06-22 2

PAGGIARINO DARIO A. CHIEF MEDICAL OFFICER

75,200 2021-06-22 3

JONES DAVID SCOTT SVP & CHIEF COMMERCIAL OFFICER

79,305 2021-06-22 2

OCUMENSION THERAPEUTICS

3,010,722 2020-12-31 1

LIU YE

  • Director
3,010,722 2020-12-31 1

MAZZO DAVID J

0 2020-02-28 0

PETERSON KRISTINE

0 2020-02-28 0

DUKER JAY S.

0 2020-02-28 0

ROSS LEONARD S SEE REMARKS

90,044 2019-06-27 0

ROGERS MICHAEL W

0 2019-06-25 0

PRICE DAVID CFO

0 2019-06-25 0

EW HEALTHCARE PARTNERS, L.P.

EW HEALTHCARE PARTNERS-A, L.P.

ESSEX WOODLANDS FUND IX-GP, L.P.

ESSEX WOODLANDS IX, LLC

  • 10% Owner
83,807,912 2018-12-31 0

BLUM LEONARD M SEE REMARKS

  • Officer
0 2018-05-14 0

BARRY JAMES J

  • Director
No longer subject to file 2018-05-07 0

EASTMAN RONALD W

  • Director
  • 10% Owner
8,606,324 2018-03-28 0

JORN DEBORA EVP, CORP. & COMM'L DEV.

  • Officer
0 2017-06-27 0

FREEDMAN LORI SEE REMARKS

  • Officer
0 2016-07-21 0

ASHTON PAUL PRESIDENT & CEO

  • Officer
  • Director
467,522 2016-03-18 0

SAVAS PETER G

  • Director
0 2015-12-03 0

HOPPER PAUL

  • Director
0 2013-12-18 0

SOJA MICHAEL VP FINANCE, CFO & TREASURER

  • Officer
0 2008-09-10 0

WOODTHORPE KATHERINE

  • Director
0 2008-06-19 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 22:15:03 UTC -0.8708 0.9408 200000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 21:45:03 UTC -0.8708 0.9408 200000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 21:15:03 UTC -0.8708 0.9408 200000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 20:45:03 UTC -0.8708 0.9408 200000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 20:15:03 UTC -0.8708 0.9408 200000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 19:45:04 UTC -0.8708 0.9408 200000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 19:15:03 UTC -0.8708 0.9408 200000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 18:45:02 UTC -0.8708 0.9408 200000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 18:15:03 UTC -0.8708 0.9408 200000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 17:45:03 UTC -0.8708 0.9408 200000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 17:15:03 UTC -0.8708 0.9408 200000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 16:45:02 UTC -0.8742 0.9442 200000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 16:15:03 UTC -0.8742 0.9442 200000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 15:45:03 UTC -0.8742 0.9442 200000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 15:15:03 UTC -0.8742 0.9442 200000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 14:45:02 UTC -0.8742 0.9442 100000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 14:15:03 UTC -0.8742 0.9442 100000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 13:45:03 UTC -0.8742 0.9442 100000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 13:15:03 UTC -0.8742 0.9442 100000
EYEPOINT PHARMACEUTICALS INC EYPT 2021-10-25 12:45:04 UTC -0.8742 0.9442 100000

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History (International Only)

Holder Net Short Position Position Date Origin
Squarepoint Ops LLC EyePoint Pharmaceuticals Inc 0.6% 2019-11-05 GERMANY
Squarepoint Ops LLC EyePoint Pharmaceuticals Inc 0.5% 2019-10-16 GERMANY

Elevate your investments